Key result
US ischemic heart disease mortality fell ~50% from 1999 to 2025.
Why the study?
Ischemic heart disease remains a leading cause of cardiovascular mortality in the United States despite decades of advances in prevention, diagnosis, and treatment, prompting evaluation of long-term trends, demographic and geographic disparities, and future mortality projections.
Observational (n=15,585,772)
Yes
Answers are grounded in this paper and cite their sources.
Although U.S. ischemic heart disease age-adjusted mortality dropped significantly from 1999 to 2025 (with a temporary pandemic-era rise between 2018 and 2021), persistent disparities remain among men, older adults, Black individuals, and rural residents.
Ischemic heart disease (IHD) remains a leading cause of cardiovascular mortality in the United States despite decades of advances in prevention, diagnosis, and treatment. This retrospective analysis evaluated long-term trends, demographic and geographic disparities, and future projections of IHD-related mortality using national death-certificate data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) for 1999 to 2025. Age-adjusted mortality rates (AAMRs) were examined with Joinpoint regression, and an optimized ensemble model was used to project mortality through 2050. More than 15.5 million IHD-related deaths were recorded, and the overall AAMR declined from 384.15 to 193.23 per 100,000 population (average annual percentage change, − 2.77), although rates rose modestly during 2018–2021 before declining again. The burden remained consistently higher among men, older adults, Black or African American individuals, non-metropolitan residents, and several high-burden states, particularly West Virginia, and most deaths occurred at home. Projections suggested continued overall decline through 2050; however, implausible negative values for some subgroups and rising urbanization-specific forecasts represent modeling artifacts that warrant cautious interpretation. Persistent disparities across sex, age, race and ethnicity, geography, and urbanization indicate that aggregate progress has not been shared equally, and sustained reductions will require equitable prevention, improved rural cardiovascular care, and targeted interventions for high-burden populations.
No takes yet. Share an insight, caveat, or question.
Mazhar et al. (2026) conducted an observational in Ischemic heart disease (IHD) (n=15,585,772). Temporal and demographic trends in ischemic heart disease mortality (2025 vs 1999) vs. Baseline year 1999 was evaluated on Annual age-adjusted mortality rate (AAMR) for IHD-related deaths per 100,000 population (AAPC -2.77, 95% CI -3.29 to -2.25, p=<0.001). Ischemic heart disease age-adjusted mortality rates in the United States declined from 384.15 to 193.23 per 100,000 between 1999 and 2025 (AAPC -2.77, 95% CI -3.29 to -2.25; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: